Induction of anaesthesia with an intravenous injection of PHAX001, a new water soluble anaesthetic compared with propofol for speed of onset and recovery from anaesthesia.

Trial Profile

Induction of anaesthesia with an intravenous injection of PHAX001, a new water soluble anaesthetic compared with propofol for speed of onset and recovery from anaesthesia.

Completed
Phase of Trial: Phase I

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs Alfaxalone (Primary) ; Propofol
  • Indications Anaesthesia
  • Focus First in man; Proof of concept; Therapeutic Use
  • Most Recent Events

    • 23 May 2016 New trial record
    • 04 May 2015 According to a Drawbridge Pharmaceuticals media release, results from this trial has been accepted for publication in the prestigious medical journal Anesthesia and Analgesia.
    • 16 Dec 2013 According to a Drawbridge Pharmaceuticals media release, twenty-four subjects will take part in the trial, with twelve subjects to receive, propofol and 12 to receive the study drug,
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top